republic-os/legislation/us/states/va/2024/sb-614.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Xylazine; penalty for manufacturing, selling, etc., for human consumption.	Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to HB 1187.	us/states/va	Virginia General Assembly	2024	SB 614	Virginia SB 614 (2024)	bill		enacted	Todd E. Pillion	4	40	9	2024-01-10	2024-04-04	openstates	ocd-bill/15bd4fe9-3513-4765-8c0d-68a8d86fbd48	https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB614	c218d0b361e1d64ecb81ce736b6f467409389ed75a14d0f6e0cc236d8a8b9758	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia SB 614 (2024) — Xylazine; penalty for manufacturing, selling, etc., for human consumption.

Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to HB 1187.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. CHAP0516 (committee substitute) — source
2. Committee substitute printed 24106043D-S1 (committee substitute) — source
3. Prefiled and ordered printed; offered 01/10/24 24104627D (committee substitute) — source
4. SB614ER (committee substitute) — source

Votes

• VOTE: Block Vote Passage (96-Y 0-N) — 95–0 (pass) · lower
• Reported from Courts of Justice (15-Y 0-N) — 15–0 (pass) · upper
• Reported from Education and Health with substitute (15-Y 0-N) — 15–0 (pass) · upper
• Reported from Finance and Appropriations (15-Y 0-N) — 15–0 (pass) · upper
• Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
• Reported from Appropriations (22-Y 0-N) — 22–0 (pass) · lower
• Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
• Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
• Reported from Courts of Justice (22-Y 0-N) — 22–0 (pass) · lower

Sponsors

• Todd E. Pillion — primary (person)
• Tara A. Durant — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2024-01-10 Prefiled and ordered printed; offered 01/10/24 24104627D filing, introduction
• 2024-01-10 Referred to Committee on Education and Health referral-committee
• 2024-01-12 Impact statement from VCSC (SB614)
• 2024-01-16 Assigned Education and Health Sub: Health Professions referral-committee
• 2024-01-25 Impact statement from DPB (SB614)
• 2024-01-26 Senate subcommittee amendments and substitutes offered
• 2024-02-01 Reported from Education and Health with substitute (15-Y 0-N) committee-passage
• 2024-02-01 Committee substitute printed 24106043D-S1 substitution
• 2024-02-01 Rereferred to Courts of Justice referral-committee
• 2024-02-02 Impact statement from VCSC (SB614S1)
• 2024-02-05 Reported from Courts of Justice (15-Y 0-N) committee-passage
• 2024-02-05 Rereferred to Finance and Appropriations referral-committee
• 2024-02-05 Impact statement from DPB (SB614S1)
• 2024-02-07 Reported from Finance and Appropriations (15-Y 0-N) committee-passage
• 2024-02-08 Constitutional reading dispensed (40-Y 0-N)
• 2024-02-09 Read second time reading-2
• 2024-02-09 Reading of substitute waived
• 2024-02-09 Committee substitute agreed to 24106043D-S1 substitution
• 2024-02-09 Engrossed by Senate - committee substitute SB614S1 substitution
• 2024-02-09 Constitutional reading dispensed (40-Y 0-N)
• 2024-02-09 Passed Senate (40-Y 0-N) passage
• 2024-02-15 Placed on Calendar
• 2024-02-15 Read first time reading-1
• 2024-02-15 Referred to Committee for Courts of Justice referral-committee
• 2024-02-16 Reported from Courts of Justice (22-Y 0-N) committee-passage
• 2024-02-16 Referred to Committee on Appropriations referral-committee
• 2024-02-21 Reported from Appropriations (22-Y 0-N) committee-passage
• 2024-02-23 Read second time reading-2
• 2024-02-26 Read third time reading-3
• 2024-02-26 Passed House BLOCK VOTE (96-Y 0-N) passage
• 2024-02-26 VOTE: Block Vote Passage (96-Y 0-N) passage
• 2024-02-29 Enrolled enrolled
• 2024-02-29 Bill text as passed Senate and House (SB614ER) passage
• 2024-02-29 Impact statement from DPB (SB614ER)
• 2024-02-29 Signed by Speaker passage
• 2024-03-03 Signed by President passage
• 2024-03-11 Enrolled Bill Communicated to Governor on March 11, 2024 enrolled
• 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024 executive-receipt
• 2024-04-04 Approved by Governor-Chapter 516 (effective 7/1/24) executive-signature
• 2024-04-04 Acts of Assembly Chapter text (CHAP0516)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/15bd4fe9-3513-4765-8c0d-68a8d86fbd48. Confidence: reported (aggregated from official Virginia legislature records).